Trauma-Informed Goal Management Training for Individuals With Post-traumatic Stress Disorder (PTSD)

Inclusion Criteria

• •Inclusion
• •Be fluent in English;
• •Must reside in Ontario;
• •Be able to provide written informed consent;
• •Be between the ages of 18 and 65 (in order to help us generalize results);
• •Meet provisional diagnosis of PTSD using a cut-off of \>30 on the PCL-5, administered at the time of screening, to be corroborated with the results of the CAPS-5;
• •Be able to attend regular online, 2-hour sessions once/week for 9 weeks, and be willing to complete the pre-, post-treatment, and follow-up assessments;
• •Have access to a computer with a working microphone and camera, and have reliable and consistent internet;
• •Exclusion
• •Use benzodiazepines daily or almost daily;
• •Use narcotics daily or almost daily;
• •Endorse alcohol/substance use symptoms on the eligibility screener that may interfere with their ability to participate in the study, to be corroborated with the results of the M.I.N.I. (to be determined by Dr. McKinnon's clinical team);
• •Have a history of Moderate to Severe Brain Injury or loss of consciousness with prolonged effects that interfere with daily functioning at school, work or family unit;
• •Have a history of neurological disorder that may interfere with their ability to participate in the study (to be determined by Dr. McKinnon's clinical team);
• •Have a diagnosis of psychotic disorder or bipolar disorder;
• •Have a diagnosis of neurodevelopmental disorder that may interfere with their ability to participate in the study (to be determined by Dr. McKinnon's clinical team);
• •Have other conditions/impairments/considerations that could interfere with completion of study tasks (to be determined by Dr. McKinnon's clinical team)
• •Have previously participated in GMT
• •Be receiving treatment with anti-cholinergics, anti-psychotic medication, or psychostimulants
• •Had ECT within the past year
• •Are currently engaged in a trauma-specific intervention (EMDR, CPT, and PE) that may impact the findings of the current study (to be determined by Dr. McKinnon's clinical team)
• •Is an active serving member of the Canadian Armed Forces